Online ISSN: 3007-0244,
Print ISSN:  2410-4280
METHODOLOGY FOR CALCULATION OF AVOIDABLE MORTALITY ON THE EXAMPLE OF CARDIOVASCULAR DISEASES IN KAZAKHSTAN
Introduction. Cardiovascular disease (CVD) related mortality remains a major preventable public health problem worldwide. A high rate of avoidable mortality indicates insufficient preventive or effective medical care that was not provided in a timely manner. However, avoidable mortality can be an indicator of health system performance. OECD countries and Canada use the measure of avoidable mortality to study the trend in causes of death. The aim of the study is to analyze preventable CVD mortality in the Republic of Kazakhstan. Materials and methods: To calculate avoidable, treatable and preventive mortality rates, we summed the standardized mortality rate (tst) by age group, including cause of death. Based on the methodology developed by the OECD, we determined the avoidable mortality for CVD in Kazakhstan in 2018. Data for Kazakhstan were taken by "Information and Computing Center of the Bureau of National Statistics of the Agency for Strategic Planning and Reforms of the Republic of Kazakhstan" Results: In the Republic of Kazakhstan from CVD, the age-standardized rates of avoidable mortality per 100,000 population amounted to 121.42 (of which 58.36 are preventive and 63.06 are treatable). It was found that the older the age of the population, the higher the rates of both preventive and treatable mortality. Conclusion: Despite the introduction of preventive programs for CVD and disease management programs, the proportion of mortality associated with curable conditions exceeds, which indicates an insufficient amount of implementation of measures for the prevention of CVD.
Number of Views: 154

Key words:

Category of articles: Original articles

Bibliography link

Kosherbayeva L., Samambaeva A., Boquete Yolanda Pena, Imamatdinova A. Methodology for calculation of avoidable mortality on the example of cardiovascular diseases in Kazakhstan // Nauka i Zdravookhranenie [Science & Healthcare]. 2022, (Vol.24) 4, pp. 101-107. doi 10.34689/SH.2022.24.4.013

Авторизируйтесь для отправки комментариев